If you are a member of SIDP or ACCP ID PRN, login to our CE Center and enter your code in the Enrollment Code box to participate in this activity at no cost.
NOTE: If you attended this CE activity live (via webinar) on July 14, 2020, AND received CE credit (i.e. a pharmacist CE statement with ACPE Universal Activity Number 0221-9999-20-276-L01-P, or Laboratory PACE credit), you are NOT allowed to also receive CE credit for this home-study activity.
This annual webcast provides updates on hot topics related to antibiotic stewardship and microbiological testing. This year’s webcast will include recent CLSI antimicrobial susceptibility testing updates for gram positive/gram negative bacteria and Candida species. We will also discuss ways to incorporate these changes in your antimicrobial stewardship efforts.
The target audience for this activity is pharmacists and Laboratory Professionals. At the completion of this activity, the participant will be able to:
- Discuss highlights from the 2020 CLSI standards for antimicrobial susceptibility testing and reporting.
- Identify rationale for recent changes in taxonomy and CLSI breakpoints for gram-positive/gram-negative bacteria as well as Candida species.
- Describe how stewardship teams can readily incorporate susceptibility data into practice through optimization of antimicrobial selection and dosing.
Audrey Schuetz, M.D., M.P.H., D(ABMM)
Professor of Laboratory Medicine and Pathology
Director of Initial Processing and Media Laboratories
Co-Director of Bacteriology Laboratory
Mayo Clinic College of Medicine and Science
Natasha N. Pettit, Pharm.D., BCPS (AQ-ID)
Clinical Pharmacy Specialist, Infectious Diseases
Clinical Pharmacy Coordinator, ID/Antimicrobial Stewardship
Pharmacy Director, Antimicrobial Stewardship Program
University of Chicago Medicine
Release Date: July 14, 2020
Expiration Date: July 14, 2023
This CE activity is jointly provided by ProCE, Inc., CLSI, and SIDP. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-20-276-H01-P has been assigned to this knowledge-based home study CE activity (initial release date 7-14-20). This CE activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. Completion of the evaluation and the post-test with a score of 70% or higher are required to receive CE credit. No partial credit will be given.
Clinical and Laboratory Standards Institute is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.(R) Program.
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed in this activity. Dr. Pettit has no relevant commercial and/or financial relationships to disclose. Dr. Schuetz has served as an Advisory Board member for Pattern Bioscience.
This activity is self-funded by SIDP, CLSI, and members of ACCP ID PRN.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.